In addition, in another study, M. Sorin et al. revealed the effective role of CXCL13 as a soluble molecule within the TME of NSCLC patients and its potential in anti-PD-1 therapy [23]. The gene discussed is CXCL13; the disease is non-small cell lung carcinoma.